Bizarre Patents
Vehicular Impact Signaling Device
An apparatus for the deployment of a visible plume to alert other motorists that a proximate motor vehicle has been involved in a collision.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8158352 | Screening of a novel hepatic syndrome and its uses The invention concerns methods of screening for a hepatic syndrome occurring in the young adult and associating cholesterol biliary microlithiasis, intrahepatic cholestasis and several mutations of the MDR3 gene. The invention is also directed to methods for the tre... | 04/17/2012 |
| 7906640 | Polynucleotide and protein involved in synaptogenesis, variants thereof, and their therapeutic and diagnostic uses The invention relates to a kit for diagnosing autism linked to a mutation in a protein belonging to the family of human neuroligins. ... | 03/15/2011 |
| 7888022 | Screening of a novel hepatic syndrome and its uses The invention concerns methods of screening for a hepatic syndrome occurring in the young adult and associating cholesterol biliary microlithiasis, intrahepatic cholestasis and several mutations of the MDR3 gene. The invention is also directed to methods for the tre... | 02/15/2011 |
| 7700569 | Use of stabilised oligonucleotides for preparing a medicine with antitumor activity The invention concerns the use of stabilized oligonucleotides comprising at least an octamer motif of the type: 5′-purine-purine-CG-pyrimdine-pyrimidine-X1X2-3′ wherein the pair X1-X2 is AT, AA, CT or TT, for preparing... | 04/20/2010 |
| 7651838 | Prenatal diagnosis method on isolated foetal cell of maternal blood The invention concerns a novel non-invasive prenatal diagnostic method implemented with a sample of maternal blood. Said method enables prenatal diagnosis on isolated non-apoptotic epithelial foetal cells of maternal blood after they have been enriched by filtration... | 01/26/2010 |
| 7632635 | Method for measuring resistance of a patient HIV-2 to protease inhibitors A search method in a biological sample containing an HIV 2 viral strain for possible resistance of said strain to treatment by an anti-protease agent, and nucleotide probes for the implementation thereof. According to methods known per se, the presence of at least o... | 12/15/2009 |
| 7601333 | Use of a tetrapeptide AcSDKP (SEQ ID No. 1) analog resistant to the angiotensin I converting enzyme for measuring glomerular filtration rate in a human or an animal and kit containing same The invention concerns the use of ACE-resistant N-acétyl-Ser-Asp-Lys-Pro analogues for preparing a reagent or marker adapted to measure a glomerular filtration rate. ... | 10/13/2009 |
| 7397024 | Phantom for the quality control of a radiotherapy treatment virtual simulation system The invention relates to a phantom for the quality control of a radiotherapy treatment virtual simulation system which comprises a medical imaging device, characterized in that it comprises: a support casing (1), ... | 07/08/2008 |
| 7384740 | Polynucleotide and protein involved in synaptogenesis variants thereof and their therapeutic and diagnostic uses The present invention provides a method of diagnosing autism linked to a mutation in the polynucleotide of SEQ ID NO: 12 or the polypeptide of SEQ ID NO: 14, or a propensity therefor, in a human, where the mutation results in altered synapse formation. ... | 06/10/2008 |
| 7351570 | HDV nucleic acid molecules and applications thereof The invention concerns nucleic acid molecules derived from novel hepatitis D virus strains or isolates constituting genotypes different from known I, II and III genotypes, their fragments, corresponding proteins and their uses as diagnostic reagents. The invention a... | 04/01/2008 |
| 7291452 | Erythrovirus and its applications The invention concerns nucleic acids derived from human V9 erythrovirus, fragments thereof, encoded polypeptides, and applications as diagnostic reagents and as immunogenic agents. ... | 11/06/2007 |
| 7262011 | Screening of a novel hepatic syndrome and its uses The invention concerns methods of screening for a hepatic syndrome occurring in the young adult and associating cholesterol biliary microlithiasis, intrahepatic cholestasis and several mutations of the MDR3 gene. The invention is also directed to methods for the tre... | 08/28/2007 |
| 7138234 | Gene involved in CADASIL, method of diagnosis and therapeutic application The invention concerns the Notch3 gene and the corresponding protein, which are involved in CADASIL. The invention concerns, in particular, methods for demonstrating mutations in this gene, which are linked to the risk of developing CADASIL and related diseases.... | 11/21/2006 |
| 7108844 | Use of stabilized oligonucleotides for preparing a medicament with antitumor activity The invention concerns the use of stabilized oligonucleotides comprising at least an octamer motif of the type: 5′-purine-purine-CG-pyrimidine-pyrimidine-X1X2-3′ wherein the pair X1-X2- is AT, AA, CT or TT, for prepari... | 09/19/2006 |
| 7030234 | Non-M, non-O HIV-1 strains, fragments and uses Retroviral strains of the non-M, non-O HIV-1 group, in particular a strain designated YBF30, its fragments and also its uses as a diagnostic reagent and as an immunogenic agent. The HIV-1 viruses which differ both from the M group and the O group exhibit the ... | 04/18/2006 |
| 6995257 | Gene involved in CADASIL, method of diagnosis and therapeutic application The invention concerns the Notch3 gene and the corresponding protein, which are involved in CADASIL. The invention concerns, in particular, methods for demonstrating mutations in this gene, which are linked to the risk of developing CADASIL. The invention also conce... | 02/07/2006 |
| 6841171 | Use of oyster flesh enzymatic hydrolysates for preparing compositions eliminating free radicals The invention concerns the use of an oyster enzymatic hydrolysate for preparing a composition eliminating free radicals. The invention is characterized in that said hydrolysate is obtainable by hydrolysis of oyster flesh by a protease. The invention is applicable in... | 01/11/2005 |
| 6794129 | Method for measuring anti-protease resistance of HIV-2 in a patient A search method in a biological sample containing an HIV 2 viral strain for possible resistance of said strain to treatment by an anti-protease agent, and nucleotide probes for the implementation thereof. According to methods known per se, the presence of at least o... | 09/21/2004 |
| 6537775 | Gene involved in cadasil, method of diagnosis and therapeutic application The invention concerns the Notch3 gene and the corresponding protein, which are involved in CADASIL. The invention concerns, in particular, methods for demonstrating mutations in this gene, which are linked to the risk of developing CADASIL. The invention... | 03/25/2003 |
| 6470124 | Device for observation inside a body providing improved quality of observation The invention concerns a device for observation inside a body, such as the body of a living being, comprising means for illuminating (110, 115, 200, 300, 400) the body inside, means for displaying an image (600, 700, 800), and a flexible conduit (300) for... | 10/22/2002 |
| 6296668 | Artificial implant intended to replace the human urinary and excretory organs The object of the invention is an implant not requiring major surgery for its insertion or for the partial replacement of any of its elements; said prosthesis can be applied for long-term placement. The implant disclosed replaces the entire urinary organs... | 10/02/2001 |
| 6270975 | Group O HIV-1, fragments of such viruses, and uses thereof Group HIV-1 retrovirus strains, particularly the strains known as BCF02, BCF01, BCF06, BCF07, BCF08, BCF11, BCF03, BCF09, BCF12, BCF13 and BCF14, fragments of said retroviruses, and the uses thereof as a diagnostic reagent and as an immunogen, are disclos... | 08/07/2001 |
| 6090378 | Composition comprising interleukin-2 and thymidine kinase for the treatment of tumors Composition for use in the treatment of tumors and the immunization of humans or animals comprising a synergistic association of cells, viruses, or bacteria expressing, transitorily, in organisms at least one gene for producing in vivo one or more immunom... | 07/18/2000 |
| 6030769 | Group O HIV-1, fragments of such viruses, and uses thereof Group HIV-1 retrovirus strains, particularly the strains known as BCF02, BCF01, BCF06, BCF07, BCF08, BCF11, BCF03, BCF09, BCF12, BCF13 and BCF14, fragments of said retroviruses, and the uses thereof as a diagnostic reagent and as an immunogen, are disclos... | 02/29/2000 |
| 5532239 | Therapeutic application of fluoroquinolone derivatives This invention relates to treatment or prevention of nephrotic syndromes by administration of a derivative of the fluoroquinolone class corresponding to the general formula: ##STR1## in which: R1 is an alkyl (1 to 4 carbon atoms), fluoroet... | 07/02/1996 |
